It is reported that in PCa, between 2 and 15% of primary tumors harbor a PTEN mutation, while between 30 and 40% exhibit an important deletion on chromosome 10q23 (6, 10–13). The gene discussed is PTEN; the disease is posterior cortical atrophy.